GILD

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

02/26 02:35 pm

Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

02/25 01:54 pm

Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy

02/25 11:09 am

Arcellx Surges as Gilead’s $7.8B Offer Locks In a 68% Premium

02/23 11:48 am

Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug

02/23 08:51 am

Xilio Therapeutics Announces Pricing of Underwritten Offering

02/11 10:34 pm

Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?

02/11 03:23 pm

Hepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally

02/11 05:00 am

Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

02/03 02:56 am

This Top Non-Tech AI Trade for 2026 Pays a Huge 11.6% Dividend

02/02 07:33 am

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

01/28 06:51 am

Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

01/27 02:43 pm

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

01/22 01:00 pm

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

01/13 08:00 am

GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

01/07 12:48 pm

3 Cash-Flow Machines Investors May Want Heading Into 2026

01/02 05:11 pm

Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million

12/24 09:36 am

3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains

12/15 02:41 pm

Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal

12/15 01:15 pm

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

12/06 10:30 am

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

12/05 06:41 am

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away

12/03 10:34 am

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

12/01 08:00 am

U.S. CAR T-Cell Therapies Market Grows at 30.4% CAGR, Soars USD 42.61 Billion by 2035

11/27 12:00 pm

Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035

11/27 10:00 am

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

11/13 02:55 pm

Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend

11/07 11:10 am

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

11/03 10:00 am

Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026

10/31 01:41 pm

Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030

10/31 06:19 am

CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High

10/29 10:20 am

Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia

10/22 06:00 am

Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf

10/21 01:30 am

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

10/21 01:30 am

NCBCP Celebrates President & CEO, Melanie L. Campbell's 30 Years of Leadership and Service During the 28th Annual Spirit of Democracy Awards Gala

10/20 03:45 pm

Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress

10/18 03:00 am

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

10/17 12:43 pm

Merck's New HIV Treatment Works As Well As Top Drug In Late Trials

10/15 12:23 pm

Multiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances

10/08 11:00 am

Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare

10/08 10:00 am

Immatics Appoints Venkat Ramanan as Chief Financial Officer

10/01 07:00 am

Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care

09/26 03:47 am

Top Security Executives Recognized at the 2025 BayAreaCISO ORBIE Awards

09/25 03:49 pm

Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

09/17 10:44 pm

Biotech Sector May Flip to Market Leader by Year-End

09/15 01:25 pm

Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

09/04 11:00 am

Pharming Group appoints Kenneth Lynard as Chief Financial Officer

09/02 01:00 am

Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy

08/21 11:45 am

Ligand to Participate in September Investor Conferences

08/19 04:00 pm

MacroGenics Revenue Doubles in Q2

08/14 04:21 pm